Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02100007
Title ME-344 Given in Combination With Hycamtin in Patients With Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications

ovarian cancer

cervical cancer

lung small cell carcinoma

Therapies

ME-344 + Topotecan

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Pinnacle Oncology Hematology Scottsdale Arizona 85258 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Oncology Hematology Care Cincinnati Ohio 45242 United States Details
University of Oklahoma Oklahoma City Oklahoma 73104 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
Tennessee Oncology, PLLC Nashville Tennessee 37203 United States Details
University of WA Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
The Bays St Mary's Hospital London England W2 1NY United Kingdom Details
Sarah Cannon Research Instititute UK London England WIG 6AD United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field